The Research Center is a 5-year project (with one-year extension) starting 1 April 2012 to 31 March 2018.
Our
hypothesis is that the interplay between human host genome expression and gut microbiota (GM) affects the development of chronic metabolic disorders, and that interventions targeting the microbiome and mucosa can therefore reduce the risk of developing metabolic dysfunctions such as obesity, Type 2 Diabetes (T2D), and cardiovascular diseases (CVD).